TUPPERWARE WKN: 901014 ISIN: US8998961044 Forum: Aktien Thema: Hauptdiskussion

Wenn du nicht drin bist kaufen save kannste nix mit falsch machen.

Morgen kann man auf l&s handeln. Nachkaufen oder warten?🤔

sehr gut....erstmal zahlen geliefert...delisting vom tisch...

Wird aufjedenfall wild zeit die nächsten Monate euch noch schöne Ostertage und kucken auf Montag ;) !!! gute nacht an alle!!!

Dann sind die drin sind mega im Vorteil ;)

Doch nicht.

L&S sollte offen haben?

So ist es bin sehr gespannt aber morgen können doch welche bei tradegate doch einkaufen odeR?

Könnte am Montag wirklich hochschnerren, das ist definitiv positiv zu sehen, das die Q geliefert wurden. Alles andere ergibt keinen Sinn.

Die alle noch nicht drin sind werden sich extrem ärgern wenn es Montag hochknallen sollte da wir schon drin sind und den dicken VORTEIL haben!!!

Delisting ist vom TISCH fürs erste. Wie gesagt der T. Plan das wird sehr interessant ich hoffe in den kommende Wochen jetzt auf was wie viele andere auch.

Die Frage ist was Montag überwiegt. Die Erleichterung über die Lieferung der Zahlen, oder die Zahlen selbst. Die Spekulation über eine Umsetzung des Turnaround Plans würde zumindest wieder mehr in den Vordergrund rücken und den Schrecken eines Delistings vertreiben.

At September 30, 2023, the Company had $14.6 million of unused lines of credit, including $13.6 million under the committed, secured Amended Credit Agreement, and $1.0 million available under various uncommitted lines around the world. As a result of the Third Amendment, the Global Tranche Revolving Commitments were reduced by $30.0 million. Between May and August 2023, the Company had no availability to borrow further under its Revolver Facility until it entered into the DRA, which provided availability of up to $21.0 million in Global Tranche Revolving Commitments, subject to liquidity and other covenants. In addition, upon entering into the DRA, $18.2 million of interest and $4.0 million of accrued fees were converted to outstanding debt. During the fourth quarter of 2023, $20.0 million of interest was converted to outstanding debt. The Forbearance Agreement, among other things, required a principal payment of the USD Term A Loans of $10.9 million, permitted continued access to the Revolver Facility but limited availability to $36.4 million, and extended the deadline for delivery of the 2022 10-K and the 2023 Forms 10-Q. As of December 31, 2022, the Company had $120.1 million of unused lines of credit, including $106.3 million under the committed, secured Amended Credit Agreement, and $13.8 million available under various uncommitted lines around the world. Long-term debt and other lease financing obligations includes a $3.3 million and $3.1 million financing liability as of September 30, 2023 and December 31, 2022, respectively, associated with the lease of the Company’s headquarters in Orlando, Florida. The obligation originated on October 30, 2020 with the commencement of the sale-leaseback agreement for the facility that matures in the fourth quarter of 2031. As of September 30, 2023, the Company had a weighted average interest rate of 12.60% with a base rate spread of 600 basis points on SOFR-based borrowings under the Amended Credit Agreement. Interest is payable in arrears and at maturity. As of September 30, 2023, the Company had a Consolidated Net Leverage Ratio of 7.20x resulting from trailing twelve months EBITDA, as defined in the Amended Credit Agreement of $94.0 million and a Consolidated Interest Coverage Ratio of 1.21x. As of December 31, 2022, the Company had a weighted-average interest rate of 7.52% with a base rate spread of 375 basis points on SOFR-based borrowings under the Amended Credit Agreement. Interest is payable in arrears and at maturity. As of December 31, 2022, the Company had a Consolidated Net Leverage Ratio of 4.73x resulting from trailing twelve months EBITDA, as defined in the Amended Credit Agreement, of $129.7 million, and a Consolidated Interest Coverage Ratio of 3.19x. The Company was in compliance with the financial covenants under its Amended Credit Agreement, as of December 31, 2022 but was forecasting non-compliance with covenants in subsequent quarters. See Note 1: Summary of Significant Accounting Policies - Going Concern and Liquidity

Das zu den Kreditlaufzeiten!!!

Each of the Credit Agreement Amendments affected the terms of our Credit Agreement as set forth in more detail in our 2022 10-K or, in case of the Sixth Amendment, and the Forbearance Agreement as otherwise disclosed. As of the date hereof and after giving effect to the Credit Agreement Amendments, the Amended Credit Agreement provides for: • global tranche revolving commitments (“Global Tranche Revolving Commitments” and the loans made pursuant thereto “Global Tranche Revolving Loans”) in an aggregate amount equal to $38.4 million (provided that global tranche revolving credit exposure may not exceed $36.4 million during the forbearance period contemplated by the Forbearance Agreement), which includes a sub-facility for letter of credit issuances in the amount of $22.3 million, maturing July 31, 2025, • term loans in an aggregate principal amount equal to $425.0 million (“USD Term A Loans”) maturing July 31, 2025, • term loans in an aggregate principal amount equal to $156.4 million (“USD Term C Loans”) maturing July 31, 2027, and • term loans in an aggregate principal amount equal to €173.4 million (“EUR Term D Loans”) maturing July 31, 2027.

Was auffällt ist das letzte Q 2023 fehlt hmmm